Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001816 · ClinicalTrials.gov registry record
The Impact of Starbright World on Children Being Treated at the NIH
A clinical trial of Child, Hospitalized, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT00001816: Completed study of Child, Hospitalized, sponsored by National Cancer Institute (NCI).
NCT00001816 is a study of Child, Hospitalized that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001816, a study of Child, Hospitalized, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to evaluate the impact of Starbright World (SBW) on hospitalized children. SBW is a virtual environment designed to link seriously ill children into an interactive online community where they can play games, learn about their condition, or talk with other ill children who are connected to the network. Our outcome evaluation of SBW will include assessments of pain, mood (anxious, depressed and energetic), anger, loneliness, and willingness to return to the NIH for treatment of children who are being treated at NIH. They will be assessed while engaging in "normal" recreational activities (in one of two available playrooms) and while using Starbright World. In addition, we will conduct a process evaluation of the implementation of Starbright World.
Conditions Studied
Study Locations (1)
Maryland
- National Cancer Institute (NCI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 1999-05 |
| Est. Completion | 2001-02 |
What the finished NCT00001816 record still lists
NCT00001816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 1 condition, with Child, Hospitalized appearing as the primary indexed condition, and to 0 interventions.
NCT00001816 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001816 about?
NCT00001816 is a clinical study titled "The Impact of Starbright World on Children Being Treated at the NIH". This study seeks to evaluate the impact of Starbright World (SBW) on hospitalized children. SBW is a virtual environment designed to link seriously ill children into an interactive online community where they can play games, learn about their condition, or talk with other ill children who are connec...
What is the current status of trial NCT00001816?
This trial is currently completed. The enrollment target is 35 participants. The study started on 1999-05. Estimated completion is 2001-02.
What conditions does trial NCT00001816 study?
This clinical trial studies the following conditions: Child, Hospitalized.
Who is sponsoring clinical trial NCT00001816?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001816 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia